HOMCY CHARLES J - Insider Non-Derivative Transactions at BridgeBio Pharma, Inc. (BBIO) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Feb 16, 2024, HOMCY CHARLES J's relationship to BridgeBio Pharma, Inc. (BBIO) is Director, and currently has 1,231,594 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BBIO insiders.

Data Source: SEC.
HOMCY CHARLES J - Insider Non-Derivative Transactions of BBIO Common Stock
HOMCY CHARLES J - Insider Non-Derivative Transactions at BBIO
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Feb 17, 2024 F -- (Common Stock) 1509 37.21 1230085
Feb 17, 2024 M -- (Common Stock) 3760 0 1231594
Nov 17, 2023 F -- (Common Stock) 1301 28.86 1226996
Nov 17, 2023 M -- (Common Stock) 3760 0 1228297
Aug 17, 2023 F -- (Common Stock) 1301 29.8 1224537
Aug 17, 2023 M -- (Common Stock) 3760 0 1225838
May 17, 2023 F -- (Common Stock) 1300 14.09 1220827
May 17, 2023 M -- (Common Stock) 3759 0 1222127
Feb 17, 2023 F -- (Common Stock) 1534 12.64 1218368
Feb 17, 2023 M -- (Common Stock) 3760 0 1219902